The company launched its manufacturing unit in the year dedicated in the production of SemiSynthetic Penicillin. 그 해에 회사는 상장되었고 주식은 인도 증권 거래소에 상장되었습니다. Antidiabetics is also supposed to be their key major therapeutic area.